Gene · 9156
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Esophageal Cancer Cells Exhibit Heterogeneity in DNA Double-Strand Break Repair and G2/M Checkpoint Arrest Associated With Cell Viability After Ionizing Radiation. | Adv Radiat Oncol | 2026 | 41725640 | PubTator, text mining | PubMed |
| Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes. | Front Immunol | 2026 | 41716387 | PubTator, text mining | PubMed |
| ssDNA-PLA, a proximity ligation assay to interrogate DNA damage response proteins involved in homologous recombination. | Biol Methods Protoc | 2026 | 41710294 | PubTator, text mining | PubMed |
| R-loop processing via REXO4-RNaseH1-mediated endo- and exo-cleavage coupling mode prevents genome instability and antitumor immunity. | Sci Adv | 2026 | 41706852 | PubTator, text mining | PubMed |
| Regulation of transcription by R loop-nucleated transcription condensate assembly. | Cell Biosci | 2026 | 41703613 | PubTator, text mining | PubMed |
| Telomere-based Risk Model for Prognosis Prediction in Clear Cell Renal Cell Carcinoma. | Curr Med Chem | 2026 | 41620921 | PubTator, text mining | PubMed |
| The human RAD52 complex undergoes phase separation and facilitates bundling and end-to-end tethering of RAD51 presynaptic filaments. | Nucleic Acids Res | 2026 | 41603734 | PubTator, text mining | PubMed |
| [Alterations in the transcriptional profile of genes in tumors as a prerequisite for personalization of treatment in breast cancer patients]. | Arkh Patol | 2026 | 41591352 | PubTator, text mining | PubMed |
| Compact bacterial recombination complexes drive efficient kilobase-scale knock-in in mammalian cells. | Nucleic Acids Res | 2026 | 41569163 | PubTator, text mining | PubMed |
| RNA-Binding Proteins in Dinoflagellates. | Int J Mol Sci | 2026 | 41516343 | PubTator, text mining | PubMed |
| IFI16 senses and protects stalled replication forks. | Mol Cell | 2026 | 41512859 | PubTator, text mining | PubMed |
| Programmable large-cargo integration: Overcoming size constraints for next-generation gene therapy. | Synth Syst Biotechnol | 2026 | 41438771 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Proliferative Senescence and Genomic Instability in Werner Syndrome and the WRN Gene Network. | Cytogenet Genome Res | 2026 | 40971347 | PubTator, text mining | PubMed |
| Disruption of protein-protein interaction hotspots in the C-terminal domain of MLH1 confers mismatch repair deficiency. | NAR Cancer | 2025 | 41480639 | PubTator, text mining | PubMed |
| DNA mismatch repair mediated by Mlh1-Pms1 endonuclease-catalyzed mispair excision. | Proc Natl Acad Sci U S A | 2025 | 41439704 | PubTator, text mining | PubMed |
| Unravelling TPX2-centered co-expression networks as key drivers of aggressive prostate cancer. | Sci Rep | 2025 | 41402347 | PubTator, text mining | PubMed |
| Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1. | J Med Chem | 2025 | 41359073 | PubTator, text mining | PubMed |
| EXO1 overexpression induces homologous recombination deficiency and enhances PARP inhibitor sensitivity in ER-positive breast cancer: modulation by N4BP2L2-Mediated restoration. | Front Cell Dev Biol | 2025 | 41323735 | PubTator, text mining | PubMed |
| Leveraging Genome-wide Association Studies to Identify Pathogenic Variants for Breast Cancer Among Multiple Continents. | Anticancer Res | 2025 | 41318116 | PubTator, text mining | PubMed |
| Molecular subtyping and a seven-gene immune signature reveal heterogeneity in tumor microenvironment and prognosis of lung adenocarcinoma. | Eur J Med Res | 2025 | 41310864 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9156/papers?page=3